Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Response to RET-Specific Therapy in RET Fusion-Positive Anaplastic Thyroid Carcinoma.

Autor: Dias-Santagata, Dora, Lennerz, Jochen K., Sadow, Peter M., Frazier, Ryan P., Govinda Raju, Sandya, Henry, Dahlia, Chung, Trisha, Kherani, Jennifer, Rothenberg, S. Michael, Wirth, Lori J.

Publikováno v: Thyroid; Sep2020, Vol. 30 Issue 9, p1384-1389, 6p

Traumatic blowout of a duodenal diverticulum: A rare clinical finding

Autor: Angus, Lambros, Larson, Brett, Egodage, Tanya, Govinda Raju, Sandya

Publikováno v: In Injury Extra November 2013 44(10-12):95-98

Radiographic and visual response to the type II RAF inhibitor tovorafenib in children with relapsed/refractory optic pathway glioma in the FIREFLY-1 trial.

Autor: Nysom K; Department of Pediatrics and Adolescent Medicine, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark., Kilburn LB; Children's National Hospital, Washington, DC, USA., Leary SES; Cancer and Blood Disorders Center, Seattle Children's, Seattle, WA, USA., Landi DB; Duke University, Durham, NC, USA., de Vos-Kerkhof E; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Perreault S; CHU Sainte-Justine, Université de Montréal, Montreal, QC, Canada., Witt O; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany., Ziegler DS; Kids Cancer Centre, Sydney Children's Hospital, Randwick, NSW, Australia.; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia.; School of Clinical Medicine, University of New South Wales, Sydney, NSW, Australia., Hernáiz Driever P; Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität Berlin, German HIT-LOGGIC-Registry for LGG in children and adolescents, Pediatric Neurooncology Program, Department of Pediatric Oncology/Hematology, Berlin, Germany., Franson AT; CS Mott Children's Hospital, University of Michigan Medical School, Ann Arbor, Michigan, USA., Baxter PA; Texas Children's Cancer Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA., Whipple NS; Primary Children's Hospital and University of Utah, Salt Lake City, UT, USA., Kline C; Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Segal D; NYU Langone Health, New York, NY, USA., Jabado N; McGill University Health Centre (MUHC) - The Montreal Children's Hospital (MCH), Montréal, QC, Canada., Bailey S; Great North Children's Hospital and Newcastle University Centre for Cancer, Newcastle-upon-Tyne, UK., McCowage G; Sydney Children's Hospitals Network, Westmead, NSW, Australia., Hansford JR; Michael Rice Centre for Hematology and Oncology, Women's and Children's Hospital, Adelaide, SA, Australia.; South Australia Health and Medical Research Institute, Adelaide, Australia; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, Australia., Khuong-Quang DA; Children's Cancer Centre, The Royal Children's Hospital Melbourne, Melbourne, Victoria, Australia., Gottardo NG; Department of Pediatric and Adolescent Oncology and Hematology, Perth Children's Hospital, Perth, Australia and Brain Tumor Research Program, Telethon Kids Cancer Centre, Telethon Kids Institute, University of Western Australia, Perth, WA, Australia., Hassall T; Children's Health Queensland Hospital and Health Service, South Brisbane, Australia., Han JW; Severance Hospital, Yonsei University Health System, Seoul, Republic of Korea., Yalon Oren M; Pediatric Hemato-Oncology Department, Sheba Medical Center, Ramat Gan, Israel., Chi SN; Pediatric Neuro-Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA., Qiu J; Day One Biopharmaceuticals, Brisbane, CA, USA., Da Costa D; Day One Biopharmaceuticals, Brisbane, CA, USA., Govinda Raju S; Day One Biopharmaceuticals, Brisbane, CA, USA., Manley P; Day One Biopharmaceuticals, Brisbane, CA, USA., Hargrave D; UCL Great Ormond Street Institute of Child Health and Great Ormond Street Hospital for Children, London, UK.

Publikováno v: Neuro-oncology [Neuro Oncol] 2024 Dec 19. Date of Electronic Publication: 2024 Dec 19.